Pancreatic Cancer Group investigates the pancreatic tumor biology to understand the underlying mechanism of disease aggressiveness and therapeutic resistance, and to identify molecular subtypes in pancreatic cancer. Our efforts are focused on identifying candidate therapeutic targets and biomarkers for therapeutic response and treatment selection. In our investigation, which involves both a global (transcriptomics and metabolomics) as well as focused strategies, we use clinical samples from multiple cohorts of pancreatic cancer patients and pre-clinical mouse model of pancreatic cancer.

Current Research projects in the Breast & Prostate Cancer Unit:
Molecular Profiles of pancreatic cancer associated with disease aggressiveness and subtypes.
Role of Inflammation in the development and progression of Pancreatic Cancer
Role of forkhead family of transcription factors in pancreatic cancer

Staff Members

Perwez Hussain
Investigator, Tenure Track
Head of Pancreatic Cancer Unit
hussainp@mail.nih.gov
Naotake Funamizu
Visiting Fellow
funamizun@mail.nih.gov
Peijun He
Biologist
hep@mail.nih.gov
Geng Zhang
Research Fellow
gengz@mail.nih.gov

[Home] | [Office of the Chief] [MG&C Section] | [ME Section] [Liver Carcinogenesis Section] |
[Complete Bibliography] | [Post Doctoral Opportunities]